Tesamorelin (5 mg)
$250.00
Tesamorelin is a growth hormone secretagogue, stimulating the natural release of growth hormone. This peptide is favored for its ability to increase lean muscle mass, reduce body fat, and enhance recovery times.
Rejuvenate yourself. Book this service now.
Book with Confidence
✔ No Travel Fees ✔ No Hidden Fees ✔ Free Booking
Tesamorelin is a synthetic analogue of growth-hormone releasing hormone (GHRH), used in research settings to explore the modulation of growth hormone (GH), insulin-like growth factor-1 (IGF-1), body composition, and visceral adiposity.
Benefits & Potential Applications
-
Stimulates endogenous GH release, leading to increased IGF-1 levels.
-
Has been shown in clinical trial settings to reduce visceral adipose tissue (VAT) in certain populations.
-
May improve fat‐quality (density) and muscle area when VAT reduction is achieved.
-
Can support research into metabolic, endocrine, and body-composition pathways (e.g., lipodystrophy, obesity, non‐alcoholic fatty liver) via GH/IGF axis modulation.
Research Application
This formulation of Tesamorelin is intended for in vitro experimentation and animal model research into endocrine pathways, body‐composition regulation, GH/IGF signalling and fat redistribution. It is not approved for cosmetic, human enhancement, or off‐label human use outside of its regulated medical context.
FAQs
How does Tesamorelin work?
It binds to GHRH receptors in the pituitary gland, stimulating release of growth hormone, which in turn elevates IGF-1 production and influences tissues including adipose, muscle and liver.
What outcomes have been demonstrated?
In clinical studies of HIV‐associated lipodystrophy, Tesamorelin reduced VAT by ~15% compared with placebo over ~26 weeks.
Improvements in fat density and muscle metrics have also been observed in responders.
What safety or side-effect considerations exist?
In controlled trials, Tesamorelin was generally well-tolerated, with injection-site reactions, peripheral edema, arthralgia among reported effects. It can raise IGF-1 and influences glucose/lipid metabolism — thus, glucose intolerance is a theoretical risk.
When might results appear in research settings?
Duration varies by model and dosage; in human clinical studies ~26 weeks showed measurable VAT reductions.
Product Usage
THIS PRODUCT IS INTENDED FOR RESEARCH USE ONLY. This designation allows usage strictly for in vitro testing and laboratory experimentation only. All product information on this website is for educational purposes only. Any bodily introduction into humans or animals is strictly forbidden unless authorized by relevant regulatory/ethical oversight. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as such.
Why Choose Us
We support cutting-edge research into endocrine, metabolic and body-composition therapies. Our Tesamorelin is offered at research grade purity, with full documentation and quality controls to facilitate your pre-clinical or translational investigations.
Related Products
-
BPC-157 / TB-500 / GHK-Cu Blend
-
GHK-Cu (individual peptide)
-
Other GH‐axis peptides and analogues
Expert Care
Skilled professionals dedicated to your well-being
Safe Procedure
Committed to safety with every treatment.
Gentle Treatment
Compassionate care with a gentle touch.
Physiological Harmony
Evidence-based treatments designed to align mind, body, and overall health
Why Choose Us
We are committed to enhancing the way you feel on the inside and the way you look on the outside, too. We have raised the bar when it comes to advancing your healthy lifestyle with an extensive list of therapies and services designed to help you boost and maintain your overall well-being.
